Coleman Dorothy 4
4 · scPharmaceuticals Inc. · Filed Nov 21, 2017
Insider Transaction Report
Form 4
Coleman Dorothy
Director
Transactions
- Conversion
Series A Preferred Stock
2017-11-21−103,024→ 0 total→ Common Stock (14,348 underlying) - Conversion
Common Stock
2017-11-21+14,348→ 14,348 total
Footnotes (2)
- [F1]Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
- [F2]All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis on November 21, 2017 and had no expiration date.